• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors

    3/6/25 4:23:00 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary
    Get the next $MODV alert in real time by email

    Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024.

    Fourth Quarter 2024 Summary:

    • Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023
    • Net loss of $23.5 million, or negative $1.64 per diluted common share
    • Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share
    • Net cash provided by operating activities during the quarter of $30.0 million and free cash flow(2) of $24.7 million
    • Contract receivables, net of contract payables, of $95.2 million as of December 31, 2024
    • In early 2025, we amended our Credit Agreement to obtain financial covenant relief in the form of a covenant holiday beginning with the fourth quarter of 2024 through the second quarter of 2025. This amendment included the issuance of a $75.0 million incremental term loan facility to support our liquidity.

    Full Year 2024 Summary:

    • Service revenue of $2,787.6 million, a 1.3% increase as compared to $2,751.2 million in 2023
    • Net loss of $201.3 million, or negative $14.14 per diluted common share
    • Adjusted EBITDA(1) of $161.1 million, adjusted net income(1) of $11.2 million and adjusted EPS(1) of $0.79 per diluted common share
    • Net cash used in operating activities in 2024 of $6.4 million and negative free cash flow(2) of $34.0 million
    • Contract receivables decreased by $26.2 million to $117.8 million as of December 31, 2024 as compared to year-end 2023 and contract payables decreased by $94.8 million to $22.6 million as of December 31, 2024 as compared to year-end 2023

     

     

    (1) Non-GAAP financial measure reconciliations and other related information about non-GAAP financial measures provided below.

    (2) Free cash flow, a non-GAAP financial measure, is calculated by us as cash flow from operations less our capital expenditures during the period that are included in our purchase of property and equipment line in our Statements of Cash Flows provided below.

    "2024 proved to be a challenging year in the dynamic and complex markets we serve," stated L. Heath Sampson, President and CEO. "The industry faced significant disruption in 2024 from Medicaid redetermination, surging healthcare utilization, and lower Medicare Advantage reimbursements—pressures that created financial strain, disrupted cash flow, and impacted our performance. Service revenue grew approximately 1% year-over-year, driven by increased NEMT ride utilization and growth in personal care, though offset by Medicaid redetermination and contract churn. We ended the year with a $95 million net contract receivable position. As utilization levels stabilize and key clients transition to a fee-for-service contract structure, we expect working capital to normalize in 2025. Looking ahead, we are positioned in 2025, having a strengthened balance sheet, to drive long-term shareholder value—all while maintaining our commitment to high-quality service for our members, customers, and the healthcare system."

    Fourth Quarter 2024 Results

    For the fourth quarter of 2024, the Company reported revenue of $702.8 million, which was consistent with the $702.8 million in revenue reported in the fourth quarter of 2023. Revenue in our NEMT segment decreased $4.0 million, or 0.8%, revenue in our PCS segment increased by $5.4 million, or 3.0%, and revenue in our Monitoring segment decreased by $1.1 million, or 5.3%, as compared to the corresponding segment performance in the fourth quarter of 2023.

    Operating income was $4.3 million, or 0.6% of revenue, in the fourth quarter of 2024, compared to $15.7 million, or 2.2% of revenue, in the fourth quarter of 2023. Net loss in the fourth quarter of 2024 was $23.5 million, or negative $1.64 per diluted common share, compared to net loss of $5.3 million, or negative $0.37 per diluted common share, in the fourth quarter of 2023. The increase in net loss for the fourth quarter of 2024 from the fourth quarter of 2023 was driven primarily by an increase in service expense of $12.1 million in addition to an increase in interest expense of $8.6 million.

    Adjusted EBITDA was $40.4 million, or 5.7% of revenue, in the fourth quarter of 2024, compared to $50.5 million, or 7.2% of revenue, in the fourth quarter of 2023. Our adjusted EBITDA was lower in 2024 than in the comparable prior year fourth quarter period due mostly to 10.4% lower gross profit across each of our segments, primarily as a result of higher service expense across each of our segments. Adjusted net income in the fourth quarter of 2024 was $2.7 million or $0.19 per diluted common share, compared to $18.4 million, or $1.29 per diluted common share, in the fourth quarter of 2023.

    Net cash provided by operating activities during the fourth quarter of 2024 was $30.0 million as compared to net cash used in operating activities of $25.6 million during the fourth quarter of 2023. Changes in operating assets and liabilities during the quarter include a settlement in contract payables of $24.7 million and a decrease in contract receivables of $7.4 million. Net cash used in investing activities during the quarter was $5.3 million, primarily related to investments in technology and purchases of monitoring devices. Net cash provided by financing activities during the quarter was $39.5 million, which resulted in a quarter ended balance on our revolving credit facility of $269.0 million.

    Full Year 2024 Results

    For the full year 2024, the Company reported revenue of $2,787.6 million, an increase of 1.3% from $2,751.2 million in revenue reported in 2023. Revenue in our NEMT segment increased by $5.8 million, or 0.3%, revenue in our PCS segment increased by $29.7 million, or 4.1%, and revenue in our Monitoring segment decreased by $0.2 million, or 0.3%, as compared to the corresponding segment performance in 2023.

    Loss from operations was $92.8 million, or 3.3% of revenue, for 2024, compared to loss from operations of $139.9 million, or 5.1% of revenue, for 2023. Net loss in 2024 was $201.3 million, or negative $14.14 per diluted common share, compared to a net loss of $204.5 million, or negative $14.43 per common share, in 2023. Both our loss from operations and our net loss in 2024 and 2023 were primarily related to the previously disclosed non-cash goodwill impairment recorded for $105.2 million and $183.1 million in the second quarter of 2024 and 2023, respectively.

    Adjusted EBITDA for 2024 was $161.1 million or 5.8% of revenue, compared to $204.4 million, or 7.4% of revenue, in 2023. Our Adjusted EBITDA was lower in 2024 primarily due to lower gross margin across each of our segments as a result of increased service expense across each of our segments. Adjusted net income for 2024 was $11.2 million or $0.79 per diluted common share, compared to $79.9 million, or $5.60 per diluted common share, for 2023.

    Net cash used in operating activities during the year was $6.4 million as compared to net cash used in operating activities of $83.0 million during 2023. Changes in operating assets and liabilities during the current year include a settlement in contract payables of $94.8 million and collections on contract receivables of $26.2 million. Net cash used in investing activities during the year was $27.6 million, primarily related to investments in technology and purchases of monitoring devices. Net cash provided by financing activities during the year was $144.4 million, which resulted in a year ended balance on our revolving credit facility of $269.0 million.

    New Board of Directors Appointments

    Modivcare today announced that Alec Cunningham and David Mounts Gonzales have been appointed to its board of directors (the "Board"), effective March 7, 2025.

    Mr. Cunningham is a proven board member and public and private-company CEO with significant national experience with Medicaid, Medicare, and other public-funded healthcare programs, who has delivered excellent operating results in development and turnaround situations. He has unique talent and deep expertise in the policies and operations of government-sponsored health insurance programs and risk-bearing provider organizations. He spent nine years with WellCare Health Plans, a managed care provider of government-sponsored health insurance programs across the United States, where he served as Chief Executive Officer from 2009 to 2013. During his tenure as CEO, Mr. Cunningham led a strategic, operational, and financial transformation of WellCare. Mr. Cunningham also served as Chief Operating Officer at Aetna, a CVS Health company and top private insurance provider in the United States. Mr. Cunningham holds an MBA from the University of Southern California and a bachelor's degree in economics from Oklahoma State University.

    Mr. Mounts Gonzales is a General Partner of the AI Catalyst Fund, a significant shareholder in the Company, which invests in public companies to enhance their use of artificial intelligence and advanced technology through strategic engagement. He is an experienced chief executive and public company director, having served as CEO of Inmar Intelligence, a data-driven commerce and analytics platform, from 2010 to 2022, including as Chairman from 2014 to 2022. Previously, he held senior leadership roles at Domino's Pizza, Inc. as EVP of Supply Chain and CFO, driving innovation in technology, product, and logistics, and at UPS, Inc., where he held multiple executive positions, including International Country Manager, Corporate Controller, and SVP of UPS Capital. His expertise in AI, analytics, and strategic cost optimization will support the Company in driving operational efficiencies and long-term value creation. Mr. Mounts Gonzales holds an MBA from the Wharton School at the University of Pennsylvania and a Bachelor of Science degree from the University of Nevada, Las Vegas.

    Leslie Norwalk, Chair of the Board, said, "We are excited to welcome Alec and David to the Board as independent directors. Their diverse expertise in healthcare and transportation will bring significant value to Modivcare. Alec's proven success in driving strong operational results across Medicare and Medicaid managed care organizations will be crucial in helping us better understand our customers, optimize operations, and advance our mission. At the same time, David's deep knowledge of technology and innovation will be key to improving our interactions with providers and supporting our cost-reduction efforts."

    The appointment of Mr. Cunningham is a part of the Board's previously announced plan to add three new independent directors, pursuant to its contractual obligations with its lenders. Modivcare is working with its lenders to identify the remaining new Board candidate. The Board is committed to a continuous refreshment process designed to provide for a membership that is comprised of directors with a range of skills and experiences that complement Modivcare's strategy and execution.

    Additionally, Modivcare previously announced that Garth Graham has resigned from his position on the Board, effective February 28, 2025. His resignation is not the result of any disagreement with the Company. "Garth's contribution to Modivcare was critical as we considered the importance of social determinants of health on our lines of business. We appreciate his years of service and wish him well," commented Leslie Norwalk.

    Fourth Quarter and Full Year 2024 Earnings Conference Call

    Modivcare will hold a conference call to discuss its financial results on Thursday, March 6, 2025 at 5:00 p.m. ET. To access the call, please dial:

    US toll-free: 1 (877) 407-8037

    International: 1 (201) 689-8037

    You may also access the conference call via webcast at investors.modivcare.com, where the call will also be archived.

    About Modivcare

    Modivcare Inc. ("Modivcare" or the "Company") is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH) by connecting members to essential care services. By doing so, Modivcare helps health plans manage risks, reduce costs, and improve overall health outcomes. Modivcare is a provider of non-emergency medical transportation (NEMT), personal care services (PCS), and monitoring solutions (Monitoring). To learn more about Modivcare, please visit www.modivcare.com.

    Non-GAAP Financial Measures and Adjustments

    In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the information contained herein may include presentations for the Company and its segments (as noted and applicable) of: (1) EBITDA, Adjusted EBITDA, Adjusted G&A expense, Adjusted EBITDA margin, Adjusted Net Income (Loss), and Adjusted EPS, all of which are non-GAAP financial measures considered by management to be performance measures; and (2) free cash flow, which is a non-GAAP financial measure considered by management to be a liquidity measure. EBITDA is defined as net income (loss) before: (1) interest expense, net; (2) provision (benefit) for income taxes; and (3) depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before (as applicable): (1) restructuring and related costs; (2) transaction and integration costs; (3) settlement related costs; (4) a one-time payor collection settlement; (5) stock-based compensation; (6) impairment of goodwill;, (7) loss on debt extinguishment; and (8) equity in net (income) loss of investee, net of tax. Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by service revenue, net. Adjusted Net Income (Loss) is calculated as net income (loss) before (as applicable): (1) restructuring and related costs; (2) transaction and integration costs; (3) settlement related costs; (4) a one-time payor collection settlement; (5) stock-based compensation; (6) impairment of goodwill; (7) loss on debt extinguishment; (8) equity in net (income) loss of investee, net of tax (9) intangible asset amortization expense; and (10) the income tax impact of such adjustments. Adjusted EPS is calculated as Adjusted Net Income (Loss) divided by the diluted weighted-average number of common shares outstanding as calculated for Adjusted Net Income (Loss). Adjusted G&A expense is calculated as G&A expense before (as applicable): (1) restructuring and related costs; (2) transaction and integration costs; (3) settlement related costs; and (4) stock-based compensation. Free cash flow is calculated as cash flow from operations less our applicable capital expenditures included in our purchase of property and equipment line in our Consolidated Statements of Cash Flows. Reconciliations of the non-GAAP financial measures used herein to their most directly comparable GAAP financial measures that are not included in the discussion above are included below. Our non-GAAP performance measures exclude expenses and amounts that are not driven by our core operating results and may be one time in nature. Excluding these expenses makes comparisons with prior periods as well as to other companies in our industry more meaningful. We believe such measures allow investors to gain a better understanding of the factors and trends affecting the ongoing operations of our business. We consider our core operations to be the ongoing activities to provide services from which we earn revenue, including direct operating costs and indirect costs to support these activities. As a result, our net income or loss in equity investee is excluded from these measures, as we do not have the ability to manage the venture, allocate resources within the venture, or directly control its operations or performance. Our free cash flow presentation (as applicable) reflects an additional way of viewing our liquidity that, when viewed together with our GAAP results, provides management, investors, and other users of our financial information with a more complete understanding of factors and trends affecting our cash flows. Our use of the term free cash flow is not intended to imply, and no inference should be made, however, that any reported amounts are free to be used without restriction for discretionary expenditures, as our use of these funds may be restricted by the terms of our outstanding indebtedness, including our credit facility, and otherwise earmarked for other non-discretionary expenditures.

    Our non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because they are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and exclude expenses that may have a material impact on our reported financial results. The presentation of non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the most directly comparable financial measures prepared in accordance with GAAP. We urge you to review the reconciliations of our non-GAAP financial measures to their most directly comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate our business.

    Forward-Looking Statements

    Certain statements contained in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. The updated guidance discussed herein constitutes forward-looking statements. Such forward-looking statements are based on current expectations, assumptions, estimates and projections about our business and our industry, and are not guarantees of our future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control or predict, which may cause actual results to be materially different from those expressed or implied herein, including but not limited to: government or private insurance program funding reductions or limitations; implementation of alternative payment models or the transition of Medicaid and Medicare beneficiaries to Managed Care Organizations; our inability to control reimbursement rates received for our services; cost containment initiatives undertaken by private third-party payors and an inability to maintain or reduce our cost of services below rates set forth by our payors; the effects of a public health emergency; inadequacies in, or security breaches of, our information technology systems; changes in the funding, financial viability or our relationships with our payors; pandemics and other infectious diseases; delays in collection, or non-collection, of our accounts receivable; any impairment of our goodwill and long-lived assets; any failure to maintain or to develop reliable, efficient and secure information technology systems; any inability to attract and retain qualified employees; any disruptions from acquisition or acquisition integration efforts; estimated income taxes being different from income taxes that we ultimately pay; weakening of general economic conditions, including the impact of inflationary pressures, rising interest rates, labor shortages, higher labor costs and supply chain challenges; any failure to successfully implement our business plan, including planned strategic divestitures of certain assets; historical operating losses and negative cash flow and any failure to improve our financial condition; significant turnover of our senior management team and across our organization; ongoing negotiations related to new capital investments may require a substantial portion of time from our management; our contracts not surviving until the end of their stated terms, or not being renewed or extended; our failure to compete effectively in the marketplace; our not being awarded contracts through the government's requests for proposals process, or our awarded contracts not being profitable; any failure to satisfy our contractual obligations or to maintain existing pledged performance and payment bonds; any failure to estimate accurately the cost of performing our contracts; the extended collection periods and uncertainty concerning the timing of the collection of outstanding contract receivables; any misclassification of the drivers we engage as independent contractors rather than as employees; significant interruptions in our communication and data services; not successfully executing on our strategies in the face of our competition; any inability to maintain relationships with existing patient referral sources; certificates of need laws or other regulatory and licensure obligations that may adversely affect our personal care integration efforts and expansion into new markets; any failure to obtain the consent of the New York Department of Health to manage the day to day operations of our licensed in-home personal care services agency business; changes in the case-mix of our personal care patients, or changes in payor mix or payment methodologies; our loss of existing favorable managed care contracts; our experiencing labor shortages in qualified employees and management; labor disputes or disruptions, in particular in New York; becoming subject to malpractice, professional negligence or other similar claims; our operating in the competitive in-home patient monitoring industry, and failing to develop and enhance related technology applications; any failure to innovate and provide services that are useful to customers and to achieve and maintain market acceptance; our lack of sole decision-making authority with respect to our minority investment in Matrix and any failure by Matrix to achieve positive financial position and results of operations; any legal challenges to the relationships or arrangements between our virtual clinical care management services and the unaffiliated physician-owned professional corporation through which such services are provided; any failure to comply with applicable data interoperability and information blocking rules; the lapse of temporary telehealth flexibilities currently permitted under the Consolidated Appropriations Act of 2023; the cost of our compliance with laws; changes to the regulatory landscape applicable to our businesses; changes in budgetary priorities of the government entities or private insurance programs that fund our services; regulations relating to privacy and security of patient and service user information; actions for false claims or recoupment of funds; civil penalties or loss of business for failing to comply with bribery, corruption and other regulations governing business with public organizations; increasing scrutiny and changing expectations with respect to environmental, social and governance matters; changes to, or violations of, licensing regulations; our contracts being subject to audit and modification by the payors with whom we contract; a loss of Medicaid coverage by Medicaid beneficiaries as a result of any state Medicaid eligibility determination processes; our existing debt agreements containing restrictions, financial covenants and cross-default provisions that limit our flexibility in operating our business; our substantial indebtedness and ability to generate sufficient cash to service our indebtedness; the expiration of our existing credit agreement or any loss of available financing alternatives; our ability to incur substantial additional indebtedness or to issue additional equity; our substantial doubt about our ability to meet our obligations as they come due within one year from the date of issuance of the financial statements for fiscal year 2024; any failure to successfully remediate any control deficiency or material weakness in our internal control over financial reporting; our dependence on our subsidiaries to fund our operations and expenses; anti-takeover provisions discouraging a change of control; and any stock price volatility.

    The Company has provided additional information about the risks facing our business in our annual report on Form 10-K and subsequent periodic and current reports most recently filed with the Securities and Exchange Commission that could impact future performance. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made and are expressly qualified in their entirety by the cautionary statements set forth herein and in our filings with the Securities and Exchange Commission, which you should read in their entirety before making an investment decision with respect to our securities. We undertake no obligation to update or revise any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable law.

    --financial tables to follow--

    Modivcare Inc.

    Unaudited Condensed Consolidated Statements of Operations

    (in thousands except share and per share data)

     

     

     

     

     

     

     

     

     

     

     

    Three months ended December 31,

     

    Year ended December 31,

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

     

    $

    702,799

     

     

    $

    702,832

     

     

    $

    2,787,586

     

     

    $

    2,751,170

     

    Grant income

     

     

    —

     

     

     

    388

     

     

     

    —

     

     

     

    5,037

     

     

     

     

     

     

     

     

     

     

    Operating expenses:

     

     

     

     

     

     

     

     

    Service expense

     

     

    597,615

     

     

     

    585,483

     

     

     

    2,367,215

     

     

     

    2,304,218

     

    General and administrative expense

     

     

    74,246

     

     

     

    75,469

     

     

     

    298,391

     

     

     

    304,564

     

    Depreciation and amortization

     

     

    26,670

     

     

     

    26,592

     

     

     

    109,465

     

     

     

    104,271

     

    Impairment of goodwill

     

     

    —

     

     

     

    —

     

     

     

    105,302

     

     

     

    183,100

     

    Total operating expenses

     

     

    698,531

     

     

     

    687,544

     

     

     

    2,880,373

     

     

     

    2,896,153

     

     

     

     

     

     

     

     

     

     

    Operating income (loss)

     

     

    4,268

     

     

     

    15,676

     

     

     

    (92,787

    )

     

     

    (139,946

    )

     

     

     

     

     

     

     

     

     

    Other expenses:

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    26,924

     

     

     

    18,351

     

     

     

    94,053

     

     

     

    69,120

     

    Loss on debt extinguishment

     

     

    —

     

     

     

    —

     

     

     

    11,797

     

     

     

    —

     

    Loss before income taxes and equity method investment

     

     

    (22,656

    )

     

     

    (2,675

    )

     

     

    (198,637

    )

     

     

    (209,066

    )

    Income tax benefit (provision)

     

     

    3,451

     

     

     

    (43

    )

     

     

    5,506

     

     

     

    4,319

     

    Equity in net income (loss) of investee, net of tax

     

     

    (4,285

    )

     

     

    (2,534

    )

     

     

    (8,147

    )

     

     

    287

     

    Net loss

     

    $

    (23,490

    )

     

    $

    (5,252

    )

     

    $

    (201,278

    )

     

    $

    (204,460

    )

     

     

     

     

     

     

     

     

     

    Loss per common share:

     

     

     

     

     

     

     

     

    Basic

     

    $

    (1.64

    )

     

    $

    (0.37

    )

     

    $

    (14.14

    )

     

    $

    (14.43

    )

    Diluted

     

    $

    (1.64

    )

     

    $

    (0.37

    )

     

    $

    (14.14

    )

     

    $

    (14.43

    )

     

     

     

     

     

     

     

     

     

    Weighted-average number of common shares outstanding:

     

     

     

     

     

     

    Basic

     

     

    14,285,225

     

     

     

    14,187,071

     

     

     

    14,239,549

     

     

     

    14,173,957

     

    Diluted

     

     

    14,285,225

     

     

     

    14,187,071

     

     

     

    14,239,549

     

     

     

    14,173,957

     

     

    Modivcare Inc.

    Unaudited Condensed Consolidated Balance Sheets

    (in thousands)

     

     

     

     

     

    December 31,

     

     

    2024

     

     

     

    2023

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    112,581

     

     

    $

    2,217

    Accounts receivable, net

     

    222,317

     

     

     

    222,537

    Contract receivables

     

    117,795

     

     

     

    143,960

    Other current assets(1)

     

    42,686

     

     

     

    36,209

    Total current assets

     

    495,379

     

     

     

    404,923

    Property and equipment, net

     

    82,409

     

     

     

    85,629

    Goodwill

     

    680,252

     

     

     

    785,554

    Intangible assets, net

     

    282,320

     

     

     

    360,935

    Equity investment

     

    31,427

     

     

     

    41,531

    Operating lease right-of-use assets

     

    36,597

     

     

     

    39,776

    Other long-term assets

     

    45,948

     

     

     

    48,927

    Total assets

    $

    1,654,332

     

     

    $

    1,767,275

     

     

     

     

    Liabilities and stockholders' equity (deficit)

    Current liabilities:

     

     

     

    Accounts payable

    $

    83,068

     

     

    $

    55,241

    Accrued contract payables

     

    22,639

     

     

     

    117,488

    Accrued expenses and other current liabilities

     

    139,176

     

     

     

    127,901

    Accrued transportation costs

     

    96,745

     

     

     

    97,245

    Current portion of operating lease liabilities

     

    8,616

     

     

     

    8,727

    Short-term debt

     

    274,250

     

     

     

    113,800

    Total current liabilities

     

    624,494

     

     

     

    520,402

    Long-term debt, net of deferred financing costs

     

    986,436

     

     

     

    983,757

    Operating lease liabilities, less current portion

     

    32,905

     

     

     

    33,784

    Other long-term liabilities(2)

     

    48,971

     

     

     

    73,137

    Total liabilities

     

    1,692,806

     

     

     

    1,611,080

     

     

     

     

    Stockholders' equity (deficit)

     

    (38,474

    )

     

     

    156,195

    Total liabilities and stockholders' equity (deficit)

    $

    1,654,332

     

     

    $

    1,767,275

    (1)

     

    Includes other receivables, prepaid expenses and other current assets and short-term restricted cash.

    (2)

     

    Includes deferred tax liabilities.

     

    Modivcare Inc.

    Unaudited Condensed Consolidated Statements of Cash Flows

    (in thousands)

     

     

     

     

     

     

     

     

     

    Three months ended December 31,

     

    Year ended December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Operating activities

     

     

     

     

     

     

     

    Net loss

    $

    (23,490

    )

     

    $

    (5,252

    )

     

    $

    (201,278

    )

     

    $

    (204,460

    )

    Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    26,670

     

     

     

    26,592

     

     

     

    109,465

     

     

     

    104,271

     

    Stock-based compensation

     

    1,890

     

     

     

    2,427

     

     

     

    6,682

     

     

     

    6,456

     

    Equity in net (income) loss of investee, before tax

     

    4,285

     

     

     

    3,517

     

     

     

    9,645

     

     

     

    (398

    )

    Deferred income taxes

     

    (19,274

    )

     

     

    (2,417

    )

     

     

    (26,027

    )

     

     

    (17,652

    )

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    105,302

     

     

     

    183,100

     

    Loss on debt extinguishment

     

    —

     

     

     

    —

     

     

     

    11,797

     

     

     

    —

     

    Reduction of right-of-use assets

     

    4,155

     

     

     

    2,469

     

     

     

    11,444

     

     

     

    12,344

     

    Other non-cash items(1)

     

    1,916

     

     

     

    1,339

     

     

     

    6,668

     

     

     

    5,246

     

    Changes in operating assets and liabilities:

     

     

     

     

     

     

     

    Contract receivables

     

    (7,364

    )

     

     

    (14,685

    )

     

     

    26,164

     

     

     

    (72,828

    )

    Contract payables

     

    (24,661

    )

     

     

    (16,088

    )

     

     

    (94,849

    )

     

     

    (76,798

    )

    Long-term contract receivables

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Other changes in operating assets and liabilities(2)

     

    65,918

     

     

     

    (23,546

    )

     

     

    28,579

     

     

     

    (22,252

    )

    Net cash provided by (used in) operating activities

     

    30,045

     

     

     

    (25,644

    )

     

     

    (6,408

    )

     

     

    (82,971

    )

     

     

     

     

     

     

     

     

    Investing activities

     

     

     

     

     

     

     

    Purchase of property and equipment

     

    (5,349

    )

     

     

    (11,145

    )

     

     

    (27,630

    )

     

     

    (42,288

    )

    Net cash used in investing activities

     

    (5,349

    )

     

     

    (11,145

    )

     

     

    (27,630

    )

     

     

    (42,288

    )

     

     

     

     

     

     

     

     

    Financing activities

     

     

     

     

     

     

     

    Net proceeds from short-term borrowings

     

    41,000

     

     

     

    30,800

     

     

     

    155,200

     

     

     

    113,800

     

    Issuance of long-term debt

     

    —

     

     

     

    —

     

     

     

    525,000

     

     

     

    —

     

    Repayment of long-term debt

     

    (1,313

    )

     

     

    —

     

     

     

    (509,970

    )

     

     

    —

     

    Payment of debt issuance costs

     

    (274

    )

     

     

    —

     

     

     

    (25,786

    )

     

     

    (376

    )

    Restricted stock surrendered for employee tax payment

     

    (29

    )

     

     

    (38

    )

     

     

    (620

    )

     

     

    (899

    )

    Other financing activities(3)

     

    152

     

     

     

    195

     

     

     

    548

     

     

     

    541

     

    Net cash provided by financing activities

     

    39,536

     

     

     

    30,957

     

     

     

    144,372

     

     

     

    113,066

     

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    64,232

     

     

     

    (5,832

    )

     

     

    110,334

     

     

     

    (12,193

    )

    Cash, cash equivalents and restricted cash at beginning of period

     

    48,884

     

     

     

    8,614

     

     

     

    2,782

     

     

     

    14,975

     

    Cash, cash equivalents and restricted cash at end of period

    $

    113,116

     

     

    $

    2,782

     

     

    $

    113,116

     

     

    $

    2,782

     

    (1)

     

    Includes amortization of deferred financing costs and debt discount.

    (2)

     

    Includes accounts receivable and other receivables, prepaid expenses and other current assets, accounts payable and accrued expenses, accrued transportation costs and other changes in operating assets and liabilities.

    (3)

    Includes proceeds from common stock issued pursuant to stock option exercise and other financing activities.

     

    Modivcare Inc.

    Unaudited Reconciliation of Non-GAAP Financial Measures

    Segment Information and Adjusted EBITDA

    (in thousands)

     

     

    Three months ended December 31, 2024

     

    NEMT

     

    PCS

     

    Monitoring

     

    Corporate and Other

     

    Total

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    495,039

     

     

    $

    186,603

     

     

    $

    19,164

     

    $

    1,993

     

     

    $

    702,799

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

    Service expense

     

    439,822

     

     

     

    148,209

     

     

     

    7,728

     

     

    1,856

     

     

     

    597,615

     

    General and administrative expense

     

    28,774

     

     

     

    20,586

     

     

     

    4,659

     

     

    20,227

     

     

     

    74,246

     

    Depreciation and amortization

     

    7,568

     

     

     

    12,746

     

     

     

    5,954

     

     

    402

     

     

     

    26,670

     

    Total operating expenses

     

    476,164

     

     

     

    181,541

     

     

     

    18,341

     

     

    22,485

     

     

     

    698,531

     

     

     

     

     

     

     

     

     

     

     

    Operating income (loss)

     

    18,875

     

     

     

    5,062

     

     

     

    823

     

     

    (20,492

    )

     

     

    4,268

     

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

    26,924

     

     

     

    26,924

     

    Income (loss) before income taxes and equity method investment

     

    18,875

     

     

     

    5,062

     

     

     

    823

     

     

    (47,416

    )

     

     

    (22,656

    )

    Income tax benefit

     

    30

     

     

     

    —

     

     

     

    —

     

     

    3,421

     

     

     

    3,451

     

    Equity in net loss of investee, net of tax

     

    (585

    )

     

     

    —

     

     

     

    —

     

     

    (3,700

    )

     

     

    (4,285

    )

    Net Income (loss)

     

    18,320

     

     

     

    5,062

     

     

     

    823

     

     

    (47,695

    )

     

     

    (23,490

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

    26,924

     

     

     

    26,924

     

    Income tax benefit

     

    (30

    )

     

     

    —

     

     

     

    —

     

     

    (3,421

    )

     

     

    (3,451

    )

    Depreciation and amortization

     

    7,568

     

     

     

    12,746

     

     

     

    5,954

     

     

    402

     

     

     

    26,670

     

    EBITDA

     

    25,858

     

     

     

    17,808

     

     

     

    6,777

     

     

    (23,790

    )

     

     

    26,653

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs(1)

     

    781

     

     

     

    268

     

     

     

    —

     

     

    6,460

     

     

     

    7,509

     

    Transaction and integration costs

     

    337

     

     

     

    (582

    )

     

     

    —

     

     

    408

     

     

     

    163

     

    Stock-based compensation

     

    —

     

     

     

    —

     

     

     

    —

     

     

    1,744

     

     

     

    1,744

     

    Equity in net loss of investee, net of tax

     

    585

     

     

     

    —

     

     

     

    —

     

     

    3,700

     

     

     

    4,285

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    27,561

     

     

    $

    17,494

     

     

    $

    6,777

     

    $

    (11,478

    )

     

    $

    40,354

     

    (1)

     

    Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

     

    Modivcare Inc.

    Unaudited Reconciliation of Non-GAAP Financial Measures

    Segment Information and Adjusted EBITDA

    (in thousands)

     

     

    Three months ended December 31, 2023

     

    NEMT

     

    PCS

     

    Monitoring

     

    Corporate and Other

     

    Total

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    499,058

     

     

    $

    181,180

     

     

    $

    20,239

     

     

    $

    2,355

     

     

    $

    702,832

     

    Grant income

     

    —

     

     

     

    388

     

     

     

    —

     

     

     

    —

     

     

     

    388

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

    Service expense

     

    432,186

     

     

     

    144,283

     

     

     

    6,896

     

     

     

    2,118

     

     

     

    585,483

     

    General and administrative expense

     

    27,710

     

     

     

    23,287

     

     

     

    6,190

     

     

     

    18,282

     

     

     

    75,469

     

    Depreciation and amortization

     

    7,090

     

     

     

    12,812

     

     

     

    6,449

     

     

     

    241

     

     

     

    26,592

     

    Total operating expenses

     

    466,986

     

     

     

    180,382

     

     

     

    19,535

     

     

     

    20,641

     

     

     

    687,544

     

     

     

     

     

     

     

     

     

     

     

    Operating income (loss)

     

    32,072

     

     

     

    1,186

     

     

     

    704

     

     

     

    (18,286

    )

     

     

    15,676

     

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    18,351

     

     

     

    18,351

     

    Income (loss) before income taxes and equity method investment

     

    32,072

     

     

     

    1,186

     

     

     

    704

     

     

     

    (36,637

    )

     

     

    (2,675

    )

    Income tax benefit (provision)

     

    (8,588

    )

     

     

    49

     

     

     

    (694

    )

     

     

    9,190

     

     

     

    (43

    )

    Equity in net income (loss) of investee, net of tax

     

    73

     

     

     

    —

     

     

     

    —

     

     

     

    (2,607

    )

     

     

    (2,534

    )

    Net Income (loss)

     

    23,557

     

     

     

    1,235

     

     

     

    10

     

     

     

    (30,054

    )

     

     

    (5,252

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    18,351

     

     

     

    18,351

     

    Income tax provision (benefit)

     

    8,588

     

     

     

    (49

    )

     

     

    694

     

     

     

    (9,190

    )

     

     

    43

     

    Depreciation and amortization

     

    7,090

     

     

     

    12,812

     

     

     

    6,449

     

     

     

    241

     

     

     

    26,592

     

    EBITDA

     

    39,235

     

     

     

    13,998

     

     

     

    7,153

     

     

     

    (20,652

    )

     

     

    39,734

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs(1)

     

    658

     

     

     

    —

     

     

     

    —

     

     

     

    2,575

     

     

     

    3,233

     

    Transaction and integration costs(2)

     

    (101

    )

     

     

    1,807

     

     

     

    16

     

     

     

    74

     

     

     

    1,796

     

    Settlement related costs

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,194

     

     

     

    1,194

     

    Stock-based compensation

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2,016

     

     

     

    2,016

     

    Equity in net (income) loss of investee, net of tax

     

    (73

    )

     

     

    —

     

     

     

    —

     

     

     

    2,607

     

     

     

    2,534

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    39,719

     

     

    $

    15,805

     

     

    $

    7,169

     

     

    $

    (12,186

    )

     

    $

    50,507

     

    (1)

     

    Includes professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

    (2)

     

    Transaction and integration costs consist of fees incurred related to Sarbanes-Oxley Act of 2002 implementation and business integration efforts.

     

    Modivcare Inc.

    Unaudited Reconciliation of Non-GAAP Financial Measures

    Segment Information and Adjusted EBITDA

    (in thousands)

     

     

    Year ended December 31, 2024

     

    NEMT

     

    PCS

     

    Monitoring

     

    Corporate and Other

     

    Total

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    1,957,275

     

     

    $

    745,299

     

     

    $

    77,739

     

     

    $

    7,273

     

     

    $

    2,787,586

     

    Grant income

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

    Service expense

     

    1,727,984

     

     

     

    599,258

     

     

     

    32,284

     

     

     

    7,689

     

     

     

    2,367,215

     

    General and administrative expense

     

    124,475

     

     

     

    92,738

     

     

     

    20,439

     

     

     

    60,739

     

     

     

    298,391

     

    Depreciation and amortization

     

    30,170

     

     

     

    51,252

     

     

     

    26,788

     

     

     

    1,255

     

     

     

    109,465

     

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    105,302

     

     

     

    —

     

     

     

    105,302

     

    Total operating expenses

     

    1,882,629

     

     

     

    743,248

     

     

     

    184,813

     

     

     

    69,683

     

     

     

    2,880,373

     

     

     

     

     

     

     

     

     

     

     

    Operating income (loss)

     

    74,646

     

     

     

    2,051

     

     

     

    (107,074

    )

     

     

    (62,410

    )

     

     

    (92,787

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    94,053

     

     

     

    94,053

     

    Loss on debt extinguishment

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    11,797

     

     

     

    11,797

     

    Income (loss) before income taxes and equity method investment

     

    74,646

     

     

     

    2,051

     

     

     

    (107,074

    )

     

     

    (168,260

    )

     

     

    (198,637

    )

    Income tax benefit (provision)

     

    (14,482

    )

     

     

    866

     

     

     

    726

     

     

     

    18,396

     

     

     

    5,506

     

    Equity in net loss of investee, net of tax

     

    (316

    )

     

     

    —

     

     

     

    —

     

     

     

    (7,831

    )

     

     

    (8,147

    )

    Net Income (loss)

     

    59,848

     

     

     

    2,917

     

     

     

    (106,348

    )

     

     

    (157,695

    )

     

     

    (201,278

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    94,053

     

     

     

    94,053

     

    Provision (benefit) for income taxes

     

    14,482

     

     

     

    (866

    )

     

     

    (726

    )

     

     

    (18,396

    )

     

     

    (5,506

    )

    Depreciation and amortization

     

    30,170

     

     

     

    51,252

     

     

     

    26,788

     

     

     

    1,255

     

     

     

    109,465

     

    EBITDA

     

    104,500

     

     

     

    53,303

     

     

     

    (80,286

    )

     

     

    (80,783

    )

     

     

    (3,266

    )

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs(1)

     

    9,973

     

     

     

    1,589

     

     

     

    1,244

     

     

     

    8,098

     

     

     

    20,904

     

    Transaction and integration costs

     

    389

     

     

     

    1,441

     

     

     

    102

     

     

     

    1,701

     

     

     

    3,633

     

    Settlement related costs

     

    —

     

     

     

    3,415

     

     

     

    —

     

     

     

    —

     

     

     

    3,415

     

    Payor collection settlement(2)

     

    5,368

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    5,368

     

    Stock-based compensation

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    5,834

     

     

     

    5,834

     

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    105,302

     

     

     

    —

     

     

     

    105,302

     

    Loss on debt extinguishment

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    11,797

     

     

     

    11,797

     

    Equity in net loss of investee, net of tax

     

    316

     

     

     

    —

     

     

     

    —

     

     

     

    7,831

     

     

     

    8,147

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    120,546

     

     

    $

    59,748

     

     

    $

    26,362

     

     

    $

    (45,522

    )

     

    $

    161,134

     

    (1)

     

    Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

    (2)

     

    Amount represents a one-time, non-recurring settlement in connection with a dispute with a payor for which the Company will cease performing services beginning in 2025, which resulted in an adjustment to historical contracts receivable recorded for the payor beginning with calendar year 2021.

     

    Modivcare Inc.

    Unaudited Reconciliation of Non-GAAP Financial Measures

    Segment Information and Adjusted EBITDA

    (in thousands)

     

     

    Year ended December 31, 2023

     

    NEMT

     

    PCS

     

    Monitoring

     

    Corporate and Other

     

    Total

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    1,951,447

     

     

    $

    715,615

     

     

    $

    77,941

     

     

    $

    6,167

     

     

    $

    2,751,170

     

    Grant income

     

    —

     

     

     

    5,037

     

     

     

    —

     

     

     

    —

     

     

     

    5,037

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

    Service expense

     

    1,709,790

     

     

     

    561,919

     

     

     

    27,025

     

     

     

    5,484

     

     

     

    2,304,218

     

    General and administrative expense

     

    115,355

     

     

     

    86,767

     

     

     

    22,971

     

     

     

    79,471

     

     

     

    304,564

     

    Depreciation and amortization

     

    27,409

     

     

     

    51,402

     

     

     

    24,536

     

     

     

    924

     

     

     

    104,271

     

    Impairment of goodwill

     

    —

     

     

     

    137,331

     

     

     

    45,769

     

     

     

    —

     

     

     

    183,100

     

    Total operating expenses

     

    1,852,554

     

     

     

    837,419

     

     

     

    120,301

     

     

     

    85,879

     

     

     

    2,896,153

     

     

     

     

     

     

     

     

     

     

     

    Operating income (loss)

     

    98,893

     

     

     

    (116,767

    )

     

     

    (42,360

    )

     

     

    (79,712

    )

     

     

    (139,946

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    69,120

     

     

     

    69,120

     

    Income (loss) before income taxes and equity method investment

     

    98,893

     

     

     

    (116,767

    )

     

     

    (42,360

    )

     

     

    (148,832

    )

     

     

    (209,066

    )

    Income tax benefit (provision)

     

    (26,602

    )

     

     

    (5,403

    )

     

     

    (1,459

    )

     

     

    37,783

     

     

     

    4,319

     

    Equity in net income (loss) of investee, net of tax

     

    1,057

     

     

     

    —

     

     

     

    —

     

     

     

    (770

    )

     

     

    287

     

    Net Income (loss)

     

    73,348

     

     

     

    (122,170

    )

     

     

    (43,819

    )

     

     

    (111,819

    )

     

     

    (204,460

    )

     

     

     

     

     

     

     

     

     

     

    Interest expense, net

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    69,120

     

     

     

    69,120

     

    Income tax provision (benefit)

     

    26,602

     

     

     

    5,403

     

     

     

    1,459

     

     

     

    (37,783

    )

     

     

    (4,319

    )

    Depreciation and amortization

     

    27,409

     

     

     

    51,402

     

     

     

    24,536

     

     

     

    924

     

     

     

    104,271

     

    EBITDA

     

    127,359

     

     

     

    (65,365

    )

     

     

    (17,824

    )

     

     

    (79,558

    )

     

     

    (35,388

    )

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs(1)

     

    12,523

     

     

     

    —

     

     

     

    —

     

     

     

    24,181

     

     

     

    36,704

     

    Transaction and integration costs(2)

     

    —

     

     

     

    2,688

     

     

     

    86

     

     

     

    1,908

     

     

     

    4,682

     

    Settlement related costs

     

    250

     

     

     

    —

     

     

     

    —

     

     

     

    9,877

     

     

     

    10,127

     

    Stock-based compensation

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    5,501

     

     

     

    5,501

     

    Impairment of goodwill

     

    —

     

     

     

    137,331

     

     

     

    45,769

     

     

     

    —

     

     

     

    183,100

     

    Equity in net (income) loss of investee, net of tax

     

    (1,057

    )

     

     

    —

     

     

     

    —

     

     

     

    770

     

     

     

    (287

    )

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    139,075

     

     

    $

    74,654

     

     

    $

    28,031

     

     

    $

    (37,321

    )

     

    $

    204,439

     

    (1)

     

    Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

    (2)

     

    Transaction and integration costs consist of fees incurred related to Sarbanes-Oxley Act of 2002 implementation and business integration efforts.

     

    Modivcare Inc.

    Unaudited Reconciliation of Non-GAAP Financial Measures

    Adjusted Net Income and Adjusted Net Income per Common Share:

    (in thousands, except share and per share data)

     

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

    Net loss

    $

    (23,490

    )

     

    $

    (5,252

    )

     

    $

    (201,278

    )

     

    $

    (204,460

    )

     

     

     

     

     

     

     

     

    Restructuring and related costs(1)

     

    7,509

     

     

     

    3,233

     

     

     

    20,904

     

     

     

    36,704

     

    Transaction and integration costs(2)

     

    163

     

     

     

    1,796

     

     

     

    3,633

     

     

     

    4,682

     

    Settlement related costs

     

    —

     

     

     

    1,194

     

     

     

    3,415

     

     

     

    10,127

     

    Payor collection settlement(3)

     

    —

     

     

     

    —

     

     

     

    5,368

     

     

     

    —

     

    Stock-based compensation

     

    1,744

     

     

     

    2,016

     

     

     

    5,834

     

     

     

    5,501

     

    Impairment of goodwill

     

    —

     

     

     

    —

     

     

     

    105,302

     

     

     

    183,100

     

    Loss on debt extinguishment

     

    —

     

     

     

    —

     

     

     

    11,797

     

     

     

    —

     

    Equity in net (income) loss of investee, net of tax

     

    4,285

     

     

     

    2,534

     

     

     

    8,147

     

     

     

    (287

    )

    Intangible asset amortization expense

     

    19,279

     

     

     

    19,775

     

     

     

    78,538

     

     

     

    79,232

     

    Tax effected impact of adjustments

     

    (6,748

    )

     

     

    (6,848

    )

     

     

    (30,453

    )

     

     

    (34,681

    )

     

     

     

     

     

     

     

     

    Adjusted net income

    $

    2,742

     

     

    $

    18,448

     

     

    $

    11,207

     

     

    $

    79,918

     

     

     

     

     

     

     

     

     

    Adjusted EPS

    $

    0.19

     

     

    $

    1.29

     

     

    $

    0.79

     

     

    $

    5.60

     

     

     

     

     

     

     

     

     

    Diluted weighted-average number of common shares outstanding

     

    14,294,179

     

     

     

    14,326,957

     

     

     

    14,256,691

     

     

     

    14,272,709

     

    (1)

     

    Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

    (2)

     

    Transaction and integration costs consist of fees incurred related to SOX implementation and business integration efforts.

    (3)

    Amount represents a one-time, non-recurring settlement in connection with a dispute with a payor for which the Company will cease performing services beginning in 2025, which resulted in an adjustment to historical contracts receivable recorded for the payor beginning with calendar year 2021.

     

    Modivcare Inc.

    Unaudited Key Statistical and Financial Data

    (in thousands, except for statistical data)

     

     

    Three months ended

     

     

     

    Year ended

     

     

     

    Three months ended

     

     

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    September 30, 2024

     

    QoQ % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    NEMT Segment

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    495,039

     

     

    $

    499,058

     

     

    (0.8

    )%

     

    $

    1,957,275

     

     

    $

    1,951,447

     

     

    0.3

    %

     

    $

    492,253

     

     

    0.6

    %

    Purchased services expense

     

    385,722

     

     

     

    371,590

     

     

    3.8

    %

     

     

    1,504,970

     

     

     

    1,456,796

     

     

    3.3

    %

     

     

    383,769

     

     

    0.5

    %

    Payroll and other expense

     

    54,100

     

     

     

    60,596

     

     

    (10.7

    )%

     

     

    223,014

     

     

     

    252,994

     

     

    (11.9

    )%

     

     

    52,780

     

     

    2.5

    %

    Service expense

    $

    439,822

     

     

    $

    432,186

     

     

    1.8

    %

     

    $

    1,727,984

     

     

    $

    1,709,790

     

     

    1.1

    %

     

    $

    436,549

     

     

    0.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Gross profit

    $

    55,217

     

     

    $

    66,872

     

     

    (17.4

    )%

     

    $

    229,291

     

     

    $

    241,657

     

     

    (5.1

    )%

     

    $

    55,704

     

     

    (0.9

    )%

    Gross margin

     

    11.2

    %

     

     

    13.4

    %

     

     

     

     

    11.7

    %

     

     

    12.4

    %

     

     

     

     

    11.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    G&A expense

    $

    28,774

     

     

    $

    27,710

     

     

    3.8

    %

     

    $

    124,475

     

     

    $

    115,355

     

     

    7.9

    %

     

    $

    30,758

     

     

    (6.5

    )%

    G&A expense adjustments:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs

     

    781

     

     

     

    658

     

     

    18.7

    %

     

     

    9,973

     

     

     

    12,523

     

     

    (20.4

    )%

     

     

    249

     

     

    213.7

    %

    Transaction and integration costs

     

    337

     

     

     

    (101

    )

     

    (433.7

    )%

     

     

    389

     

     

     

    —

     

     

    N/M

     

     

     

    —

     

     

    N/M

     

    Settlement related costs

     

    —

     

     

     

    —

     

     

    N/M

     

     

     

    —

     

     

     

    250

     

     

    (100.0

    )%

     

     

    —

     

     

    N/M

     

    Adjusted G&A expense

    $

    27,656

     

     

    $

    27,153

     

     

    1.9

    %

     

    $

    114,113

     

     

    $

    102,582

     

     

    11.2

    %

     

    $

    30,509

     

     

    (9.4

    )%

    Adjusted G&A expense % of revenue

     

    5.6

    %

     

     

    5.4

    %

     

     

     

     

    5.8

    %

     

     

    5.3

    %

     

     

     

     

    6.2

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

    $

    18,320

     

     

    $

    23,557

     

     

    (22.2

    )%

     

    $

    59,848

     

     

    $

    73,348

     

     

    (18.4

    )%

     

    $

    12,692

     

     

    44.3

    %

    Net income margin

     

    3.7

    %

     

     

    4.7

    %

     

     

     

     

    3.1

    %

     

     

    3.8

    %

     

     

     

     

    2.6

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    27,561

     

     

    $

    39,719

     

     

    (30.6

    )%

     

    $

    120,546

     

     

    $

    139,075

     

     

    (13.3

    )%

     

    $

    30,563

     

     

    (9.8

    )%

    Adjusted EBITDA margin

     

    5.6

    %

     

     

    8.0

    %

     

     

     

     

    6.2

    %

     

     

    7.1

    %

     

     

     

     

    6.2

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total paid trips (thousands)

     

    9,543

     

     

     

    8,798

     

     

    8.5

    %

     

     

    36,800

     

     

     

    34,559

     

     

    6.5

    %

     

     

    9,418

     

     

    1.3

    %

    Average monthly members (thousands)

     

    29,382

     

     

     

    32,914

     

     

    (10.7

    )%

     

     

    29,545

     

     

     

    33,648

     

     

    (12.2

    )%

     

     

    30,023

     

     

    (2.1

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Revenue per member per month

    $

    5.62

     

     

    $

    5.05

     

     

    11.3

    %

     

    $

    5.52

     

     

    $

    4.83

     

     

    14.3

    %

     

    $

    5.47

     

     

    2.7

    %

    Revenue per trip

    $

    51.87

     

     

    $

    56.72

     

     

    (8.6

    )%

     

    $

    53.19

     

     

    $

    56.47

     

     

    (5.8

    )%

     

    $

    52.27

     

     

    (0.8

    )%

    Utilization

     

    10.8

    %

     

     

    8.9

    %

     

     

     

     

    10.4

    %

     

     

    8.6

    %

     

     

     

     

    10.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Purchased services per trip

    $

    40.42

     

     

    $

    42.24

     

     

    (4.3

    )%

     

    $

    40.90

     

     

    $

    42.15

     

     

    (3.0

    )%

     

    $

    40.75

     

     

    (0.8

    )%

    Payroll and other per trip

     

    5.67

     

     

     

    6.89

     

     

    (17.7

    )%

     

     

    6.06

     

     

     

    7.32

     

     

    (17.2

    )%

     

     

    5.60

     

     

    1.3

    %

    Total service expense per trip

    $

    46.09

     

     

    $

    49.13

     

     

    (6.2

    )%

     

    $

    46.96

     

     

    $

    49.47

     

     

    (5.1

    )%

     

    $

    46.35

     

     

    (0.6

    )%

     

    N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison and, thus, the percentage has been removed.

    Modivcare Inc.

    Unaudited Key Statistical and Financial Data

    (in thousands, except for statistical data)

     

     

    Three months ended

     

     

     

    Year ended

     

     

     

    Three months ended

     

     

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    September 30, 2024

     

    QoQ % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    PCS Segment

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    186,603

     

     

    $

    181,180

     

     

    3.0

    %

     

    $

    745,299

     

     

    $

    715,615

     

     

    4.1

    %

     

    $

    188,518

     

     

    (1.0

    )%

    Service expense

     

    148,209

     

     

     

    144,283

     

     

    2.7

    %

     

     

    599,258

     

     

     

    561,919

     

     

    6.6

    %

     

     

    151,745

     

     

    (2.3

    )%

    Gross profit

    $

    38,394

     

     

    $

    36,897

     

     

    4.1

    %

     

    $

    146,041

     

     

    $

    153,696

     

     

    (5.0

    )%

     

    $

    36,773

     

     

    4.4

    %

    Gross Margin

     

    20.6

    %

     

     

    20.4

    %

     

     

     

     

    19.6

    %

     

     

    21.5

    %

     

     

     

     

    19.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    G&A expense

    $

    20,586

     

     

    $

    23,287

     

     

    (11.6

    )%

     

    $

    92,738

     

     

    $

    86,767

     

     

    6.9

    %

     

    $

    23,823

     

     

    (13.6

    )%

    G&A expense adjustments

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs

     

    268

     

     

     

    —

     

     

    N/M

     

     

     

    1,589

     

     

     

    —

     

     

    N/M

     

     

     

    15

     

     

    1686.7

    %

    Transaction and integration costs

     

    (582

    )

     

     

    1,807

     

     

    (132.2

    )%

     

     

    1,441

     

     

     

    2,688

     

     

    (46.4

    )%

     

     

    146

     

     

    (498.6

    )%

    Settlement related costs

     

    —

     

     

     

    —

     

     

    N/M

     

     

     

    3,415

     

     

     

    —

     

     

    N/M

     

     

     

    2,610

     

     

    (100.0

    )%

    Adjusted G&A expense

    $

    20,900

     

     

    $

    21,480

     

     

    (2.7

    )%

     

    $

    86,293

     

     

    $

    84,079

     

     

    2.6

    %

     

    $

    21,052

     

     

    (0.7

    )%

    Adjusted G&A expense % of revenue

     

    11.2

    %

     

     

    11.9

    %

     

     

     

     

    11.6

    %

     

     

    11.7

    %

     

     

     

     

    11.2

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income (loss)

    $

    5,062

     

     

    $

    1,235

     

     

    309.9

    %

     

    $

    2,917

     

     

    $

    (122,170

    )

     

    (102.4

    )%

     

    $

    8

     

     

    63175.0

    %

    Net income (loss) margin

     

    2.7

    %

     

     

    0.7

    %

     

     

     

     

    0.4

    %

     

     

    (17.1

    )%

     

     

     

     

    —

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    17,494

     

     

    $

    15,805

     

     

    10.7

    %

     

    $

    59,748

     

     

    $

    74,654

     

     

    (20.0

    )%

     

    $

    15,721

     

     

    11.3

    %

    Adjusted EBITDA margin

     

    9.4

    %

     

     

    8.7

    %

     

     

     

     

    8.0

    %

     

     

    10.4

    %

     

     

     

     

    8.3

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Total hours (thousands)

     

    7,042

     

     

     

    7,074

     

     

    (0.5

    )%

     

     

    28,229

     

     

     

    27,826

     

     

    1.4

    %

     

     

    7,174

     

     

    (1.8

    )%

    Revenue per hour

    $

    26.50

     

     

    $

    25.61

     

     

    3.5

    %

     

    $

    26.40

     

     

    $

    25.72

     

     

    2.6

    %

     

    $

    26.28

     

     

    0.8

    %

    Service expense per hour

    $

    21.05

     

     

    $

    20.40

     

     

    3.2

    %

     

    $

    21.23

     

     

    $

    20.19

     

     

    5.2

    %

     

    $

    21.15

     

     

    (0.5

    )%

     

    N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison and, thus, the percentage has been removed.

    Modivcare Inc.

    Unaudited Key Statistical and Financial Data

    (in thousands, except for statistical data)

     

     

    Three months ended

     

     

     

    Year ended

     

     

     

    Three months ended

     

     

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    September 30, 2024

     

    QoQ % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Monitoring Segment

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Service revenue, net

    $

    19,164

     

     

    $

    20,239

     

     

    (5.3

    )%

     

    $

    77,739

     

     

    $

    77,941

     

     

    (0.3

    )%

     

    $

    19,448

     

     

    (1.5

    )%

    Service expense

     

    7,728

     

     

     

    6,896

     

     

    12.1

    %

     

     

    32,284

     

     

     

    27,025

     

     

    19.5

    %

     

     

    8,018

     

     

    (3.6

    )%

    Gross profit

    $

    11,436

     

     

    $

    13,343

     

     

    (14.3

    )%

     

    $

    45,455

     

     

    $

    50,916

     

     

    (10.7

    )%

     

    $

    11,430

     

     

    0.1

    %

    Gross Margin

     

    59.7

    %

     

     

    65.9

    %

     

     

     

     

    58.5

    %

     

     

    65.3

    %

     

     

     

     

    58.8

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    G&A expense

    $

    4,659

     

     

    $

    6,190

     

     

    (24.7

    )%

     

    $

    20,439

     

     

    $

    22,971

     

     

    (11.0

    )%

     

    $

    4,332

     

     

    7.5

    %

    G&A expense adjustments

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs

     

    —

     

     

     

    —

     

     

    N/M

     

     

     

    1,244

     

     

     

    —

     

     

    N/M

     

     

     

    45

     

     

    (100.0

    )%

    Transaction and integration costs

     

    —

     

     

     

    16

     

     

    (100.0

    )%

     

     

    102

     

     

     

    86

     

     

    18.6

    %

     

     

    2

     

     

    (100.0

    )%

    Adjusted G&A expense

    $

    4,659

     

     

    $

    6,174

     

     

    (24.5

    )%

     

    $

    19,093

     

     

    $

    22,885

     

     

    (16.6

    )%

     

    $

    4,285

     

     

    8.7

    %

    Adjusted G&A expense % of revenue

     

    24.3

    %

     

     

    30.5

    %

     

     

     

     

    24.6

    %

     

     

    29.4

    %

     

     

     

     

    22.0

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income (loss)

    $

    823

     

     

    $

    10

     

     

    8130.0

    %

     

    $

    (106,348

    )

     

    $

    (43,819

    )

     

    142.7

    %

     

    $

    18

     

     

    4472.2

    %

    Net income (loss) margin

     

    4.3

    %

     

     

    —

    %

     

     

     

     

    (136.8

    )%

     

     

    (56.2

    )%

     

     

     

     

    0.1

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    6,777

     

     

    $

    7,169

     

     

    (5.5

    )%

     

    $

    26,362

     

     

    $

    28,031

     

     

    (6.0

    )%

     

    $

    7,145

     

     

    (5.2

    )%

    Adjusted EBITDA margin

     

    35.4

    %

     

     

    35.4

    %

     

     

     

     

    33.9

    %

     

     

    36.0

    %

     

     

     

     

    36.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Average monthly members (thousands)

     

    249

     

     

     

    253

     

     

    (1.6

    )%

     

     

    247

     

     

     

    244

     

     

    1.2

    %

     

     

    246

     

     

    1.2

    %

    Revenue per member per month

    $

    25.65

     

     

    $

    26.67

     

     

    (3.8

    )%

     

    $

    26.23

     

     

    $

    26.62

     

     

    (1.5

    )%

     

    $

    26.35

     

     

    (2.7

    )%

    Service expense per member per month

    $

    10.35

     

     

    $

    9.09

     

     

    13.9

    %

     

    $

    10.89

     

     

    $

    9.23

     

     

    18.0

    %

     

    $

    10.86

     

     

    (4.7

    )%

     

    N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison, thus, the percentage has been removed.

    Modivcare Inc.

    Unaudited Key Statistical and Financial Data

    (in thousands)

     

     

    Three months ended

     

     

     

    Year ended

     

     

     

    Three months ended

     

     

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    September 30, 2024

     

    QoQ % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Corporate and Other Segment

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    G&A expense

    $

    20,227

     

     

    $

    18,282

     

     

    10.6

    %

     

    $

    60,739

     

     

    $

    79,471

     

     

    (23.6

    )%

     

    $

    11,990

     

     

    68.7

    %

    G&A expense adjustments

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs

     

    6,460

     

     

     

    2,575

     

     

    150.9

    %

     

     

    8,098

     

     

     

    24,181

     

     

    (66.5

    )%

     

     

    —

     

     

    N/M

     

    Transaction and integration costs

     

    408

     

     

     

    74

     

     

    451.4

    %

     

     

    1,701

     

     

     

    1,908

     

     

    (10.8

    )%

     

     

    1,219

     

     

    (66.5

    )%

    Settlement related costs

     

    —

     

     

     

    1,194

     

     

    (100.0

    )%

     

     

    —

     

     

     

    9,877

     

     

    (100.0

    )%

     

     

    —

     

     

    N/M

     

    Stock-based compensation

     

    1,744

     

     

     

    2,016

     

     

    (13.5

    )%

     

     

    5,834

     

     

     

    5,501

     

     

    6.1

    %

     

     

    340

     

     

    412.9

    %

    Adjusted G&A expense

    $

    11,615

     

     

    $

    12,423

     

     

    (6.5

    )%

     

    $

    45,106

     

     

    $

    38,004

     

     

    18.7

    %

     

    $

    10,431

     

     

    11.4

    %

    Adjusted G&A expense % of consolidated revenue

     

    1.7

    %

     

     

    1.8

    %

     

     

     

     

    1.6

    %

     

     

    1.4

    %

     

     

     

     

    1.5

    %

     

     

     

    Three months ended

     

     

     

    Year ended

     

     

     

    Three months ended

     

     

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    December 31, 2024

     

    December 31, 2023

     

    % Change

     

    September 30, 2024

     

    QoQ % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Consolidated Modivcare Inc.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    G&A expense

    $

    74,246

     

     

    $

    75,469

     

     

    (1.6

    )%

     

    $

    298,391

     

     

    $

    304,564

     

     

    (2.0

    )%

     

    $

    70,903

     

     

    4.7

    %

    G&A expense adjustments

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and related costs

     

    7,509

     

     

     

    3,233

     

     

    132.3

    %

     

     

    20,904

     

     

     

    36,704

     

     

    (43.0

    )%

     

     

    309

     

     

    2330.1

    %

    Transaction and integration costs

     

    163

     

     

     

    1,796

     

     

    (90.9

    )%

     

     

    3,633

     

     

     

    4,682

     

     

    (22.4

    )%

     

     

    1,367

     

     

    (88.1

    )%

    Settlement related costs

     

    —

     

     

     

    1,194

     

     

    (100.0

    )%

     

     

    3,415

     

     

     

    10,127

     

     

    (66.3

    )%

     

     

    2,610

     

     

    (100.0

    )%

    Stock-based compensation

     

    1,744

     

     

     

    2,016

     

     

    (13.5

    )%

     

     

    5,834

     

     

     

    5,501

     

     

    6.1

    %

     

     

    340

     

     

    412.9

    %

    Adjusted G&A expense

    $

    64,830

     

     

    $

    67,230

     

     

    (3.6

    )%

     

    $

    264,605

     

     

    $

    247,550

     

     

    6.9

    %

     

    $

    66,277

     

     

    (2.2

    )%

    Adjusted G&A expense % of revenue

     

    9.2

    %

     

     

    9.6

    %

     

     

     

     

    9.5

    %

     

     

    9.0

    %

     

     

     

     

    9.4

    %

     

     

     

    N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison and, thus, the percentage has been removed.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250306568933/en/

    Investor Relations

    ICR Healthcare

    [email protected]

    Get the next $MODV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MODV

    DatePrice TargetRatingAnalyst
    8/9/2024$35.00Mkt Perform → Outperform
    Barrington Research
    5/6/2024$50.00Hold → Buy
    Lake Street
    2/23/2024$60.00 → $40.00Buy → Hold
    Deutsche Bank
    2/23/2024$60.00 → $39.00Buy → Hold
    Jefferies
    8/3/2022$145.00Overweight
    Stephens
    2/28/2022$190.00 → $155.00Outperform
    Barrington Research
    2/3/2022$180.00 → $150.00Buy
    Deutsche Bank
    12/17/2021$180.00Buy
    Deutsche Bank
    More analyst ratings

    $MODV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Ai Catalyst Fund, Lp bought $1,677,000 worth of shares (420,000 units at $3.99) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      2/3/25 9:56:40 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Coliseum Capital Management, Llc bought $9,995,856 worth of shares (1,502,424 units at $6.65) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/14/25 7:32:58 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Q Global Capital Management, L.P. bought $48,385 worth of shares (3,837 units at $12.61) and sold $5,400,260 worth of shares (749,002 units at $7.21) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/13/25 6:35:04 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 9:05:42 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 5:07:48 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/9/24 7:46:13 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution

      Modivcare Inc. (NASDAQ:MODV), a technology-enabled healthcare services company that provides supportive care solutions to address the social determinants of health, today announced the planned departures of two members of its executive leadership team as the company continues to align its structure with its evolving business model and modernization strategy. Barb Gutierrez, Chief Financial Officer, and Jessica Kral, Chief Information Officer, will be departing the company following a period of transition. Barb's and Jessica's departures come as Modivcare evolves its organizational structure in an effort to support the next phase of its modernization strategy—built on the financial and tech

      5/5/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    SEC Filings

    See more

    $MODV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MODV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • ModivCare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - ModivCare Inc (0001220754) (Filer)

      5/8/25 4:52:15 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 8-K filed by ModivCare Inc.

      8-K - ModivCare Inc (0001220754) (Filer)

      5/5/25 6:34:16 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form DEFA14A filed by ModivCare Inc.

      DEFA14A - ModivCare Inc (0001220754) (Filer)

      4/30/25 4:57:23 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare upgraded by Barrington Research with a new price target

      Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00

      8/9/24 9:17:22 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare upgraded by Lake Street with a new price target

      Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00

      5/6/24 8:28:24 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously

      2/23/24 7:11:03 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Silvers Daniel B.

      3 - ModivCare Inc (0001220754) (Issuer)

      4/28/25 7:00:13 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • New insider Mounts Gonzales David claimed ownership of 2,130,000 shares (SEC Form 3)

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:46:20 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Cunningham Alexander R.

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:33:30 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Leadership Updates

    Live Leadership Updates

    See more
    • Modivcare Announces Changes to Board of Directors

      Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Daniel Silvers has been appointed to its board of directors (the "Board"), effective April 24, 2025. The appointment of Mr. Silvers completes the Board's previously announced plan to add three new independent directors pursuant to its contractual obligations with its lenders. "We welcome Mr. Silvers to the Board and are confide

      4/25/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Changes to Board of Directors

      Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern

      2/14/25 6:00:00 AM ET
      $EHTH
      $KAI
      $MODV
      $TVTY
      Specialty Insurers
      Finance
      Industrial Machinery/Components
      Industrials
    • GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600

      NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema

      3/27/24 6:12:00 PM ET
      $FOXF
      $GE
      $MMM
      $MODV
      Motor Vehicles
      Consumer Discretionary
      Consumer Electronics/Appliances
      Technology

    $MODV
    Financials

    Live finance-specific insights

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0

      3/6/25 4:23:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary